<i> Helicobacter pylori</i> ( H. pylori ) eradication rates achieved with a proton pump inhibitor (PPI), amoxicillin and clarithromycin have recently decreased to about 75% because of the increase in clarithromycin resistance in Japan. In the present study, H. pylori resistance rates against clarithromycin, amoxicillin and metronidazole were investigated in pediatric patients and eradication rates were evaluated when tailored antibiotics regimens based on antibiotic sensitivity data were used. We isolated H. pylori endoscopically from 77 pediatric patients suffering from abdominal symptoms. The susceptibility tests of H. pylori strains to clarithromycin, amoxicillin and metronidazole were examined and eradication therapy was tailored using the appropriate antibiotics. Seventy-seven patients were treated with a mean age of 12.16 ± 3.34 years (range, 4.92-19.75) consisting of 40 males and 37 females. The average resistance rates between 1998 and 2016 to clarithromycin, amoxicillin and metronidazole were 54.5% (42 of 77), 6.5% (5 of 77) and 5.2% (4 of 77) respectively. The prevalence of clarithromycin resistance increased significantly over time to reach 88.9% by 2013-2016. Successful eradication rates using tailored antibiotic treatment was 93.8% (61 of 65). Clarithromycin-based eradication therapy rate reached 92.6% against clarithromycin-sensitive strains. Metronidazole-based initial eradication therapy also had a high successful rate (97.0%) to clarithromycin-resistant strains. Although high rates of clarithromycin resistant H. pylori reaching about 90% were observed in Japanese children, tailored eradication therapy using the appropriate antibiotic agents were highly successful. H. pylori sensitivity testing and eradication therapy with appropriate antibacterial agents may contribute to accomplishment of high initial eradication rates and consequently reducing the incidence of developing gastric cancer.
Parkin, D.M. (2004) International Variation. Oncogene, 23, 6329-6340. https://doi.org/10.1038/sj.onc.1207726
Hatakeyama, M. and Higashi, H. (2005) Helicobacter Pylori CagA: A New Paradigm for Bacterial Carcinogenesis. Cancer Science, 96, 835-843. https://doi.org/10.1111/j.1349-7006.2005.00130.x
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L. and Cogliano, V. (2009) A Review of Human Carcinogens—Part B: Biological Agents. The Lancet Oncology, 10, 321-322. https://doi.org/10.1016/s1470-2045(09)70096-8
IARC (2012) A Review of Human Carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 100, 1-441.
Ito, M., Takata, S., Tatsugami, M., Wada, Y., Imagawa, S., Matsumoto, Y., Takamura, A., Kitamura, S., Matsuo, T., Tanaka, S., Haruma, K. and Chayama, K. (2009) Clinical Prevention of Gastric Cancer by Helicobacter Pylori Eradication Therapy: A Systematic Review. Journal of Gastroenterology, 44, 365-371. https://doi.org/10.1007/s00535-009-0036-8
Kato, M., Asaka, M., Ono, S., Nakagawa, M., Nakagawa, S., Shimizu, Y., Chuma, M., Kawakami, H., Komatsu, Y., Hige, S. and Takeda, H. (2007) Eradication of Helicobacter Pylori for Primary Gastric Cancer and Secondary Gastric Cancer after Endoscopic Mucosal Resection. Journal of Gastroenterology, 42, 16-20. https://doi.org/10.1007/s00535-006-1928-5
Lee, Y.C., Chiang, T.H., Chou, C.K., Tu, Y.K., Liao, W.C., Wu, M.S. and Graham, D.Y. (2016) Association between Helicobacter Pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-Analysis. Gastroenterology, 150, 1113-1124. https://doi.org/10.1053/j.gastro.2016.01.028
Ma, J.L., Zhang, L., Brown, L.M., Li, J.Y., Shen, L., Pan, K.F., Liu, W.D., Hu, Y., Han, Z.X., Crystal-Mansour, S., Pee, D., Blot, W.J., Fraumeni, J.F., Jr., You, W.C. and Gail, M.H. (2012) Fifteen-Year Effects of Helicobacter Pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and Mortality. Journal of the National Cancer Institute, 104, 488-492. https://doi.org/10.1093/jnci/djs003
Mabe, K., Takahashi, M., Oizumi, H., Tsukuma, H., Shibata, A., Fukase, K., Matsuda, T., Takeda, H. and Kawata, S. (2009) Does Helicobacter Pylori Eradication Therapy for Peptic Ulcer Prevent Gastric Cancer. World Journal of Gastroenterology, 15, 4290-4297. https://doi.org/10.3748/wjg.15.4290
Take, S., Mizuno, M., Ishiki, K., Hamada, F., Yoshida, T., Yokota, K., Okada, H. and Yamamoto, K. (2015) Seventeen-Year Effects of Eradicating Helicobacter Pylori on the Prevention of Gastric Cancer in Patients with Peptic Ulcer; a Prospective Cohort Study. Journal of Gastroenterology, 50, 638-644. https://doi.org/10.1007/s00535-014-1004-5
Kobayashi, I., Murakami, K., Kato, M., Kato, S., Azuma, T., Takahashi, S., Uemura, N., Katsuyama, T., Fukuda, Y., Haruma, K., Nasu, M. and Fujioka, T. (2007) Changing Antimicrobial Susceptibility Epidemiology of Helicobacter pylori Strains in Japan between 2002 and 2005. Journal of Clinical Microbiology, 45, 4006-4010. https://doi.org/10.1128/JCM.00740-07
Murakami, K., Sakurai, Y., Shiino, M., Funao, N., Nishimura, A. and Asaka, M. (2016) Vonoprazan, a Novel Potassium-Competitive Acid Blocker, as a Component of First-Line and Second-Line Triple Therapy for Helicobacter pylori Eradication: A Phase III, Randomised, Double-Blind Study. Gut, 65, 1439-1446. https://doi.org/10.1136/gutjnl-2015-311304
Nishizawa, T., Maekawa, T., Watanabe, N., Harada, N., Hosoda, Y., Yoshinaga, M., Yoshio, T., Ohta, H., Inoue, S., Toyokawa, T., Yamashita, H., Saito, H., Kuwai, T., Katayama, S., Masuda, E., Miyabayashi, H., Kimura, T., Nishizawa, Y., Takahashi, M. and Suzuki, H. (2015) Clarithromycin versus Metronidazole as First-Line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan. Journal of Clinical Gastroenterology, 49, 468-471.
Chemotherapy, J.S.F. (2000) Antimicrobial Susceptibility Subcommittee on Helicobacter pylori MIC Breakpoints for Clarithromycin and Amoxicillin. Japan Society of Chemotherapy, 48, 561-567.
Testing, E.C.A.S. (2017) Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 7.0 ed.
Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S. and Asaka, M. (2008) Effect of Eradication of Helicobacter pylori on Incidence of Metachronous Gastric Carcinoma after Endoscopic Resection of Early Gastric Cancer: An Open-Label, Randomised Controlled Trial. The Lancet, 372, 392-397.
Gisbert, J.P., Khorrami, S., Carballo, F., Calvet, X., Gene, E. and Dominguez-Munoz, E. (2004) Meta-Analysis: Helicobacter pylori Eradication Therapy vs. Antisecretory Non-Eradication Therapy for the Prevention of Recurrent Bleeding from Peptic Ulcer. Alimentary Pharmacology & Therapeutics, 19, 617-629. https://doi.org/10.1111/j.1365-2036.2004.01898.x
Wong, B.C., Lam, S.K., Wong, W.M., Chen, J.S., Zheng, T.T., Feng, R.E., Lai, K.C., Hu, W.H., Yuen, S.T., Leung, S.Y., Fong, D.Y., Ho, J., Ching, C.K. and Chen, J.S. (2004) Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China: A Randomized Controlled Trial. JAMA, 291, 187-194. https://doi.org/10.1001/jama.291.2.187
Correa, P., Fontham, E.T., Bravo, J.C., Bravo, L.E., Ruiz, B., Zarama, G., Realpe, J. L., Malcom, G.T., Li, D., Johnson, W.D. and Mera, R. (2000) Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori Therapy. Journal of the National Cancer Institute, 92, 1881-1888. https://doi.org/10.1093/jnci/92.23.1881
Iijima, K., Ohara, S., Sekine, H., Koike, T., Kato, K., Asaki, S., Shimosegawa, T. and Toyota, T. (2000) Changes in Gastric Acid Secretion Assayed by Endoscopic Gastrin Test before and after Helicobacter pylori Eradication. The Gut, 46, 20-26. https://doi.org/10.1136/gut.46.1.20
Kang, J.M., Kim, N., Shin, C.M., Lee, H.S., Lee, D.H., Jung, H.C. and Song, I.S. (2012) Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia after Helicobacter pylori Eradication: A Three-Year Follow-Up Study in Korea. Helicobacter, 17, 86-95. https://doi.org/10.1111/j.1523-5378.2011.00918.x
Kato, M., Terao, S., Adachi, K., Nakajima, S. ando, T., Yoshida, N., Uedo, N., Murakami, K., Ohara, S., Ito, M., Uemura, N., Shimbo, T., Watanabe, H., Kato, T. and Ida, K. (2013) Changes in Endoscopic Findings of Gastritis after Cure of H. pylori Infection: Multicenter Prospective Trial. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society, 25, 264-273.
Kodama, M., Murakami, K., Okimoto, T., Sato, R., Uchida, M., Abe, T., Shiota, S., Nakagawa, Y., Mizukami, K. and Fujioka, T. (2012) Ten-Year Prospective Follow-Up of Histological Changes at Five Points on the Gastric Mucosa as Recommended by the Updated Sydney System after Helicobacter pylori Eradication. Journal of Gastroenterology, 47, 394-403. https://doi.org/10.1007/s00535-011-0504-9
Ohkusa, T., Fujiki, K., Takashimizu, I., Kumagai, J., Tanizawa, T., Eishi, Y., Yokoyama, T. and Watanabe, M. (2001) Improvement in Atrophic Gastritis and Intestinal Metaplasia in Patients in Whom Helicobacter pylori Was Eradicated. Annals of Internal Medicine, 134, 380-386. https://doi.org/10.7326/0003-4819-134-5-200103060-00010
Rokkas, T., Pistiolas, D., Sechopoulos, P., Robotis, I. and Margantinis, G. (2007) The Long-Term Impact of Helicobacter pylori Eradication on Gastric Histology: A Systematic Review and Meta-Analysis. Helicobacter, 12, 32-38. https://doi.org/10.1111/j.1523-5378.2007.00563.x
Sung, J.J., Lin, S.R., Ching, J.Y., Zhou, L.Y., To, K.F., Wang, R.T., Leung, W.K., Ng, E.K., Lau, J.Y., Lee, Y.T., Yeung, C.K., Chao, W. and Chung, S.C. (2000) Atrophy and Intestinal Metaplasia One Year after Cure of H. pylori Infection: A Prospective, Randomized Study. Gastroenterology, 119, 7-14. https://doi.org/10.1053/gast.2000.8550
Wang, J., Xu, L., Shi, R., Huang, X., Li, S.W., Huang, Z. and Zhang, G. (2011) Gastric Atrophy and Intestinal Metaplasia before and after Helicobacter pylori Eradication: A Meta-Analysis. Digestion, 83, 253-260. https://doi.org/10.1159/000280318
Watanabe, H., Yamaguchi, N., Kuwayama, H., Sekine, C., Uemura, N., Kaise, M., Nakamura, T., Kubo, M., Yoshida, S., Haruma, K., Inoue, M., Shimatani, T., Sanuki, E., Mieno, H., Kawanishi, M., Nakazawa, S. and Tanaka, T. (2003) Improvement in Gastric Histology Following Helicobacter pylori Eradication Therapy in Japanese Peptic Ulcer Patients. The Journal of International Medical Research, 31, 362-369. https://doi.org/10.1177/147323000303100502
Maehata, Y., Nakamura, S., Fujisawa, K., Esaki, M., Moriyama, T., Asano, K., Fuyuno, Y., Yamaguchi, K., Egashira, I., Kim, H., Kanda, M., Hirahashi, M. and Matsumoto, T. (2012) Long-Term Effect of Helicobacter pylori Eradication on the Development of Metachronous Gastric Cancer after Endoscopic Resection of Early Gastric Cancer. Gastrointestinal Endoscopy, 75, 39-46.
Masuyama, H., Yoshitake, N., Sasai, T., Nakamura, T., Masuyama, A., Zuiki, T., Kurashina, K., Mieda, M., Sunada, K., Yamamoto, H., Togashi, K., Terano, A. and Hiraishi, H. (2015) Relationship between the Degree of Endoscopic Atrophy of the Gastric Mucosa and Carcinogenic Risk. Digestion, 91, 30-36. https://doi.org/10.1159/000368807
Take, S., Mizuno, M., Ishiki, K., Nagahara, Y., Yoshida, T., Yokota, K. and Oguma, K. (2007) Baseline Gastric Mucosal Atrophy Is a Risk Factor Associated with the Development of Gastric Cancer after Helicobacter pylori Eradication Therapy in Patients with Peptic Ulcer Diseases. Journal of Gastroenterology, 42, 21-27. https://doi.org/10.1007/s00535-006-1924-9
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N. and Schlemper, R.J. (2001) Helicobacter pylori Infection and the Development of Gastric Cancer. The New England Journal of Medicine, 345, 784-789. https://doi.org/10.1056/NEJMoa001999
Kato, S., Kikuchi, S. and Nakajima, S. (2008) When Does Gastric Atrophy Develop in Japanese chIldren? Helicobacter, 13, 278-281. https://doi.org/10.1111/j.1523-5378.2008.00611.x
Obayashi, N., Ohtsuka, Y., Hosoi, K., Ikuse, T., Jimbo, K., Aoyagi, Y., Fujii, T., Kudo, T., Asaoka, D., Hojo, M., Nagahara, A., Watanabe, S. and Shimizu, T. (2016) Comparison of Gene Expression between Pediatric and Adult Gastric Mucosa with Helicobacter pylori Infection. Helicobacter, 21, 114-123. https://doi.org/10.1111/hel.12245
Sugano, K., Tack, J., Kuipers, E.J., Graham, D.Y., El-Omar, E.M., Miura, S., Haruma, K., Asaka, M., Uemura, N. and Malfertheiner, P. (2015) Kyoto Global Consensus Report on Helicobacter pylori Gastritis. Gut, 64, 1353-1367. https://doi.org/10.1136/gutjnl-2015-309252
Hashinaga, M., Okimoto, T., Kodama, M., Mizukami, K., Ogawa, R., Okamoto, K., Shutou, M., Fukuda, K., Sonoda, A., Fukuda, M., Honda, S., Yamaoka, Y. and Murakami, K. (2016) Drug Resistance in Japan; The Presesnt Status of Helicobacter pylori; The Totaled Results of the Resistant Strain Survey in 2013 and 2014, Wagakunini okeru yakuzaitaisei Helicobacter pylori no Genjo—2013-2014 nendo taiseikin surveillance no syuukei houkoku. Japanese Journal of Helicobacter Research, 17, 45-49.
Kato, S. and Fujimura, S. (2010) Primary Antimicrobial Resistance of Helicobacter pylori in Children during the Past 9 Years. Pediatrics International, 52, 187-190. https://doi.org/10.1111/j.1442-200X.2009.02915.x
Kato, S., Fujimura, S., Udagawa, H., Shimizu, T., Maisawa, S., Ozawa, K. and Iinuma, K. (2002) Antibiotic Resistance of Helicobacter pylori Strains in Japanese Children. Journal of Clinical Microbiology, 40, 649-653. https://doi.org/10.1128/JCM.40.2.649-653.2002
Kato, S., Konno, M., Maisawa, S., Tajiri, H., Yoshimura, N., Shimizu, T., Toyoda, S., Nakayama, Y. and Iinuma, K. (2004) Results of Triple Eradication Therapy in Japanese Children: A Retrospective Multicenter Study. Journal of Gastroenterology, 39, 838-843. https://doi.org/10.1007/s00535-004-1398-6
Okamura, T., Suga, T., Nagaya, T., Arakura, N., Matsumoto, T., Nakayama, Y. and Tanaka, E. (2014) Antimicrobial Resistance and Characteristics of Eradication Therapy of Helicobacter pylori in Japan: A Multi-Generational Comparison. Helicobacter, 19, 214-220. https://doi.org/10.1111/hel.12124
Okuda, M., Kikuchi, S., Mabe, K., Osaki, T., Kamiya, S., Fukuda, Y. and Kato, M. (2017) Nationwide Survey of Helicobacter pylori Treatment for Children and Adolescents in Japan. Pediatrics International, 59, 57-61. https://doi.org/10.1111/ped.13038
Glupczynski, Y. (1998) Antimicrobial Resistance in Helicobacter pylori: A Global Overview. Acta Gastro-Enterologica Belgica, 61, 357-366. https://doi.org/10.1007/978-94-011-4882-5_42
Kim, J.J., Reddy, R., Lee, M., Kim, J.G., El-Zaatari, F.A., Osato, M.S., Graham, D.Y. and Kwon, D.H. (2001) Analysis of Metronidazole, Clarithromycin and Tetracycline Resistance of Helicobacter pylori Isolates from Korea. Journal of Antimicrobial Chemotherapy, 47, 459-461. https://doi.org/10.1093/jac/47.4.459
Ueki, N., Miyake, K., Kusunoki, M., Shindo, T., Kawagoe, T., Futagami, S., Tsukui, T., Inagaki, H. and Sakamoto, C. (2009) Impact of Quadruple Regimen of Clarithromycin Added to Metronidazole-Containing Triple Therapy against Helicobacter pylori Infection Following Clarithromycin-Containing Triple-Therapy Failure. Helicobacter, 14, 91-99. https://doi.org/10.1111/j.1523-5378.2009.00664.x
Graham, D.Y., Lu, H. and Yamaoka, Y. (2007) A Report Card to Grade Helicobacter pylori Therapy. Helicobacter, 12, 275-278. https://doi.org/10.1111/j.1523-5378.2007.00518.x
Sugimoto, M., Uotani, T., Sahara, S., Ichikawa, H., Yamade, M., Sugimoto, K. and Furuta, T. (2014) Efficacy of Tailored Helicobacter pylori Eradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion. Helicobacter, 19, 312-318. https://doi.org/10.1111/hel.12128
Koletzko, S., Jones, N.L., Goodman, K.J., Gold, B., Rowland, M., Cadranel, S., Chong, S., Colletti, R.B., Casswall, T., Elitsur, Y., Guarner, J., Kalach, N., Madrazo, A., Megraud, F., Oderda, G. and H pylori Working Groups of ESPGHAN and NASPGHAN (2011) Evidence-Based Guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori Infection in Children. Journal of Pediatric Gastroenterology and Nutrition, 53, 230-243.
Kawai, T., Yamagishi, T., Yagi, K., Kataoka, M., Kawakami, K., Sofuni, A., Itoi, T., Sakai, Y., Moriyasu, F., Osaka, Y., Takagi, Y., Aoki, T., Rimbara, E., Noguchi, N. and Sasatsu, M. (2008) Tailored Eradication Therapy Based on Fecal Helicobacter pylori Clarithromycin Sensitivities. Journal of Gastroenterology and Hepatology, 23, S171-S174. https://doi.org/10.1111/j.1440-1746.2008.05408.x